Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression. Read more about Penalized nonlinear mixed effects model to identify biomarkers that predict disease progression.
Mapping eQTL by leveraging multiple tissues and DNA methylation. Read more about Mapping eQTL by leveraging multiple tissues and DNA methylation.
Residual Weighted Learning for Estimating Individualized Treatment Rules. Read more about Residual Weighted Learning for Estimating Individualized Treatment Rules.
Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development. Read more about Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development.
Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules. Read more about Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.
Principal Components Adjusted Variable Screening. Read more about Principal Components Adjusted Variable Screening.
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Read more about Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.
Quantifying the Impact of Non-coding Variants on Transcription Factor-DNA Binding. Read more about Quantifying the Impact of Non-coding Variants on Transcription Factor-DNA Binding.
PreMeta: a tool to facilitate meta-analysis of rare-variant associations. Read more about PreMeta: a tool to facilitate meta-analysis of rare-variant associations.
Semiparametric regression analysis of interval-censored competing risks data. Read more about Semiparametric regression analysis of interval-censored competing risks data.